跳至主要内容
临床试验/NCT00916864
NCT00916864已完成不适用

Biomarker for Rapid Diagnosis of Hemispheric Stroke

Johann Wolfgang Goethe University Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
250
试验地点
1
主要终点
Diagnostic accuracy (sensitivity and specificity for diagnosing cerebral ischemia and intracerebral hemorrhage)

研究概览

简要总结

The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments [NR2-peptide] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hemiparesis
  • at least one sign of cortical involvement (e.g., aphasia, neglect, gaze deviation, reduced level of consciousness)
  • hospital admission within 4.5 hours after symptom onset

排除标准

  • stroke/TIA within the last 3 months
  • traumatic brain injury within the last 3 months
  • history of brain tumor

结局指标

主要结局

Diagnostic accuracy (sensitivity and specificity for diagnosing cerebral ischemia and intracerebral hemorrhage)

时间窗: 9 months

次要结局

未报告次要终点

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验